查詢結果分析
相關文獻
- Direct-acting Antivirals for Patients with Chronic Hepatitis C and Hepatocellular Carcinoma in Taiwan
- Direct-acting Antivirals for Patients with Chronic Hepatitis C and Hepatocellular Carcinoma in Taiwan
- Cure or Curd: Modification of Lipid Profiles and Cardio-cerebrovascular Events after Hepatitis C Virus Eradication
- Cure or Curd: Modification of Lipid Profiles and Cardio-cerebrovascular Events after Hepatitis C Virus Eradication
- 肝細胞癌之經皮酒精注射治療
- 漫談北北區處配電自動化輔助運轉系統(DAAS)建置運轉維護與應用
- 使用干涉病毒蛋白素α-2β(Interferon α-2β)治療頭頸部的血管瘤(Hemangiomas)
- 血液透析病患C型肝炎感染的甲型干擾素(Interferon-α 2b)治療
- 慢性C型肝炎以Interferon治癒後復發時,改以Ribavirin加Interferon alfa-2b治療的成本效益
- 2002年C型肝炎治療共識簡介
頁籤選單縮合
題名 | Direct-acting Antivirals for Patients with Chronic Hepatitis C and Hepatocellular Carcinoma in Taiwan= |
---|---|
作者 | Chi, Chen-ta; Chen, Chi-yi; Su, Chien-wei; Chen, Po-yueh; Chu, Chi-jen; Lan, Keng-hsin; Lee, I-cheng; Hou, Ming-chih; Huang, Yi-hsiang; |
期刊 | Journal of Microbiology, Immunology and Infection |
出版日期 | 20210600 |
卷期 | 54:3 2021.06[民110.06] |
頁次 | 頁385-395 |
分類號 | 418.285 |
語文 | eng |
關鍵詞 | DAA; HCC; Interferon; Recurrence; SVR; |